Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (1183)	10/25/1999 4:39:00 PM
From: DanZ	Read Replies (1) \| Respond to of 5582

<I NEVER invest money in something that isn't 100% proven.> LOL. Every stock is a gamble to a certain extent because nobody can predict the future. Even "proven" companies like IBM, Microsoft, Intel, Home Depot, etc., have set backs. A risk free investment carries a rate of return of 5% to 6 1/2%. Sorry, but that's not good enough for me. At any rate, Gumtech has proven some things that you don't give them credit for. For example, they increased their revenue over 100% Y to Y and improved their gross margin considerably last quarter. This proves that the new strategic plan put in place by the new management is working. The risk to reward of owning GUMM is very good, and I am confident that it will pay off big in the long run. Judging from your comment, you don't sound like the type of person who would have invested in Microsoft, Home Depot, or Intel when they were penny stocks. That's fine, but you shouldn't ridicule others who understand the risks of investing in GUMM and have decided that the potential return justifies the risk. As for Zicam, I mitigated my risk by trying it several times, as has my wife, co-workers, other family members, and people on the Internet that I trust. Funny how all of our experiences are completely different than yours. If you really did use Zicam, either you didn't have a cold or the ICAMs in a shorts' nose are different than everyone else's. <Why invest money in a product that isn't proven yet?> I can't speak for anybody else, but I didn't invest in a product. I invested in a company that has a rapidly growing gum business that justifies a stock price of at least 20 (IMO). Zicam is nothing but a bonus, albeit it could be a huge one. How much do you think one will have to pay for GUMM if the clinical studies come back positive? If you answer honestly, you'll have an answer to your question. <Do you think PFE would hype a new drug before they had conclusive clinical evidence that it worked?> I'm assuming that you are implying that Gumtech has hyped Zicam. Nothing is further from the truth. They haven't hyped it at all. In fact, they haven't even started advertising it in earnest yet. Publicity from articles in Woman's World and Self Magazines isn't advertising. The company may not have even had anything to do with those articles. Regards, Dan

To: Hank who wrote (1183)	10/25/1999 4:53:00 PM
From: out_of_the_loop	Respond to of 5582

<<You've mentioned several times that you're a PFE holder. I hold PFE too. Great company. Do you think PFE would hype a new drug before they had conclusive clinical evidence that it worked?>> Well, gee, yes, they would. cnn.com Dr. Joe Feczko of Pfizer, Trovan's manufacturer, said, "This risk assessment requires additional scientific evaluation and analysis in order to provide physicians with proper clinical guidance to use Trovan safely and effectively. The degree of risk associated with Trovan use is not markedly different when compared with other widely used antibiotics." *** You do not need to take this seriously. I was just playing around,but you will find these in most pharmas closets. Sorry Zicam did not work for you. Good luck with your investments. Time will tell whether you are right or not.

To: Hank who wrote (1183)	10/25/1999 6:54:00 PM
From: Mike M	Read Replies (1) \| Respond to of 5582

. Do you think PFE would hype a new drug before they had conclusive clinical evidence that it worked? Hank, I don't think that is a fair question. GUMM does have conclusive evidence. I am absolutely certain of that. They have the results of the "wild virus study", the first clinical. You know that they are unable to release those results if they have any hope of publication. I think it fair to say that NEJM won't publish but I believe someone will. GUMM is further going above and beyond by conducting a 2d study, "innoculation induced virus". PFE is a great company. I believe that if PFE were to own Zicam they too would operate within the legal limits of the law and that they would do exactly what Gel Tech is doing.